当前位置: 首页 > 详情页

Expression Profile of microRNAs in Hypertrophic Cardiomyopathy and Effects of microRNA-20 in Inducing Cardiomyocyte Hypertrophy Through Regulating Gene MFN2

文献详情

资源类型:

收录情况: ◇ SCIE

机构: [1]Department of Hypertension Research, Beijing Anzhen Hospital, Capital Medical University, Beijing, China. [2]Beijing Institute of Heart Lung and Blood Vessel Diseases, Beijing, China. [3]Beijing Laboratory for Cardiovascular Precision Medicine (PXM2017_014226_000037), Beijing, China
出处:
ISSN:

关键词: miRNA-20 Mfn2 genetic miRNA array analysis cardiomyocyte hypertrophy

摘要:
Myocardial hypertrophy is an important cause of heart failure and sudden death. Studies have shown that Mitofusin-2 (MFN2) is downregulated in myocardial hypertrophy, but the upstream regulation mechanism underlying its downexpression in cardiomyocytes is still unclear. This study aims to identify the expression profile of microRNAs (miRNAs) in hypertrophic cardiomyopathy (HCM) and explore the function of miRNA-20 in inducing cardiomyocyte hypertrophy through regulating MFN2. Through miRNA + mRNA microarray analysis, 1451 miRNAs were identified, 367 miRNAs expressed differently between groups. Meanwhile, a number of 24,718 mRNAs were identified, among which 5850 mRNAs were upregulated and 3005 mRNAs were downregulated in HCM group compared with the control group. Expression of hsa-miRNA-20a-5p was 2.26 times higher in the HCM group compared with the control group and 7 target gene prediction programs predicted MFN2 as a target of miRNA-20. In vitro model of hypertrophic cardiomyocytes displayed high expression level of miRNA-20, atrial natriuretic peptide (ANP) mRNA, and protein, accompanying low expression level of Mfn2 mRNA and protein, which meant miRNA-20 played a role in cardiomyocyte hypertrophy and might interact with MFN2 to function. Thereafter, overexpression of miRNA-20 led to cell hypertrophy accompanied with lowly expressed Mfn2 mRNA and protein. When transfected with miRNA-20 inhibitors, the expression of miRNA-20 and ANP gene was attenuated and MFN2 was the other way around. The cell surface area of Ang II group and mimic group was significantly larger compared with the control group, and in the inhibitor+Ang II group, the area was significantly decreased compared with the Ang II group. Dual-luciferase assays showed that miRNA-20 bound to 3 ' untranslated region of MFN2 and inhibited its expression. In conclusion, hypertrophic myocardium and normal myocardium have different miRNA expression profiles and the effect of miRNA-20 reducing the expression of MFN2 plays a role in promoting cardiomyocyte hypertrophy.

基金:
语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2018]版:
大类 | 3 区 生物
小类 | 4 区 生化与分子生物学 4 区 细胞生物学 4 区 遗传学
最新[2023]版:
大类 | 4 区 生物学
小类 | 4 区 生化与分子生物学 4 区 细胞生物学 4 区 遗传学
JCR分区:
出版当年[2017]版:
Q3 GENETICS & HEREDITY Q3 BIOCHEMISTRY & MOLECULAR BIOLOGY Q3 CELL BIOLOGY
最新[2023]版:
Q2 GENETICS & HEREDITY Q3 BIOCHEMISTRY & MOLECULAR BIOLOGY Q3 CELL BIOLOGY

影响因子: 最新[2023版] 最新五年平均 出版当年[2017版] 出版当年五年平均 出版前一年[2016版] 出版后一年[2018版]

第一作者:
第一作者机构: [1]Department of Hypertension Research, Beijing Anzhen Hospital, Capital Medical University, Beijing, China. [2]Beijing Institute of Heart Lung and Blood Vessel Diseases, Beijing, China. [3]Beijing Laboratory for Cardiovascular Precision Medicine (PXM2017_014226_000037), Beijing, China
通讯作者:
通讯机构: [1]Department of Hypertension Research, Beijing Anzhen Hospital, Capital Medical University, Beijing, China. [2]Beijing Institute of Heart Lung and Blood Vessel Diseases, Beijing, China. [3]Beijing Laboratory for Cardiovascular Precision Medicine (PXM2017_014226_000037), Beijing, China [*1]Department of Hypertension Research, Beijing Anzhen Hospital, Capital Medical University, No. 2 Anzhen Road, Chaoyang District, Beijing 100029, China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:16409 今日访问量:0 总访问量:869 更新日期:2025-01-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 首都医科大学宣武医院 技术支持:重庆聚合科技有限公司 地址:北京市西城区长椿街45号宣武医院